< Back to previous page
Researcher
Matthias Bauwens
- Disciplines:Medical imaging and therapy, Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Member
From9 Mar 2009 → 10 Sep 2011
Publications
1 - 6 of 6
- In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis(2013)
Authors: Matthias Bauwens, Stijn Hendrickx, Yicheng Ni, Luc Mortelmans, Felix Mottaghy, Alfons Verbruggen
Pages: 187 - 200 - Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis(2011)
Authors: Matthias Bauwens, Marijke De Saint-Hubert, Luc Mortelmans, Uwe Himmelreich, Felix Mottaghy, Alfons Verbruggen
Pages: 381 - 392 - Optimal buffer choice of the radiosynthesis of Ga-68-Dotatoc for clinical application(2010)
Authors: Matthias Bauwens, Rufael Chekol, Guy Bormans, Alfons Verbruggen
Pages: 753 - 758 - Preliminary In Vivo Evaluation of [I-131]-2-Iodo-D-Phenylalanine as a Potential Radionuclide Therapeutic Agent in R1M-Fluc Rhabdomyosarcoma Tumor-Bearing NuNu Mice Using Bioluminescent Imaging(2010)
Authors: Matthias Bauwens
Pages: 225 - 231 - Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding(2008)
Authors: Matthias Bauwens
Pages: 872 - 881 - Method for stabilizing non carrier added 2-[F-18]fluoromethyl-L-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation(2008)
Authors: Matthias Bauwens
Pages: 425 - 432